Cargando…

Organ-on-a-chip: the next generation platform for risk assessment of radiobiology

Organ-on-a-chip devices have been widely used in biomedical science and technology, for example for experimental regenerative medicine and precision healthcare. The main advantage of organ-on-a-chip technology is the facility to build a specific human model that has functional responses on the level...

Descripción completa

Detalles Bibliográficos
Autores principales: Quan, Yi, Sun, Miao, Tan, Zhaoyi, Eijkel, Jan C. T., van den Berg, Albert, van der Meer, Andries, Xie, Yanbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057494/
https://www.ncbi.nlm.nih.gov/pubmed/35515392
http://dx.doi.org/10.1039/d0ra05173j
_version_ 1784697909239873536
author Quan, Yi
Sun, Miao
Tan, Zhaoyi
Eijkel, Jan C. T.
van den Berg, Albert
van der Meer, Andries
Xie, Yanbo
author_facet Quan, Yi
Sun, Miao
Tan, Zhaoyi
Eijkel, Jan C. T.
van den Berg, Albert
van der Meer, Andries
Xie, Yanbo
author_sort Quan, Yi
collection PubMed
description Organ-on-a-chip devices have been widely used in biomedical science and technology, for example for experimental regenerative medicine and precision healthcare. The main advantage of organ-on-a-chip technology is the facility to build a specific human model that has functional responses on the level of organs or tissues, thereby avoiding the use of animal models, as well as greatly improving new drug discovery processes for personal healthcare. An emerging application domain for organs-on-chips is the study of internal irradiation for humans, which faces the challenges of the lack of a clear model for risk estimation of internal irradiation. We believe that radiobiology studies will benefit from organ-on-a-chip technology by building specific human organ/tissues in vitro. In this paper, we briefly reviewed the state-of-the-art in organ-on-a-chip research in different domains, and conclude with the challenges of radiobiology studies at internal low-dose irradiation. Organ-on-a-chip technology has the potential to significantly improve the radiobiology study as it can mimic the function of human organs or tissues, and here we summarize its potential benefits and possible breakthrough areas, as well as its limitations in internal low-dose radiation studies.
format Online
Article
Text
id pubmed-9057494
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-90574942022-05-04 Organ-on-a-chip: the next generation platform for risk assessment of radiobiology Quan, Yi Sun, Miao Tan, Zhaoyi Eijkel, Jan C. T. van den Berg, Albert van der Meer, Andries Xie, Yanbo RSC Adv Chemistry Organ-on-a-chip devices have been widely used in biomedical science and technology, for example for experimental regenerative medicine and precision healthcare. The main advantage of organ-on-a-chip technology is the facility to build a specific human model that has functional responses on the level of organs or tissues, thereby avoiding the use of animal models, as well as greatly improving new drug discovery processes for personal healthcare. An emerging application domain for organs-on-chips is the study of internal irradiation for humans, which faces the challenges of the lack of a clear model for risk estimation of internal irradiation. We believe that radiobiology studies will benefit from organ-on-a-chip technology by building specific human organ/tissues in vitro. In this paper, we briefly reviewed the state-of-the-art in organ-on-a-chip research in different domains, and conclude with the challenges of radiobiology studies at internal low-dose irradiation. Organ-on-a-chip technology has the potential to significantly improve the radiobiology study as it can mimic the function of human organs or tissues, and here we summarize its potential benefits and possible breakthrough areas, as well as its limitations in internal low-dose radiation studies. The Royal Society of Chemistry 2020-10-28 /pmc/articles/PMC9057494/ /pubmed/35515392 http://dx.doi.org/10.1039/d0ra05173j Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Chemistry
Quan, Yi
Sun, Miao
Tan, Zhaoyi
Eijkel, Jan C. T.
van den Berg, Albert
van der Meer, Andries
Xie, Yanbo
Organ-on-a-chip: the next generation platform for risk assessment of radiobiology
title Organ-on-a-chip: the next generation platform for risk assessment of radiobiology
title_full Organ-on-a-chip: the next generation platform for risk assessment of radiobiology
title_fullStr Organ-on-a-chip: the next generation platform for risk assessment of radiobiology
title_full_unstemmed Organ-on-a-chip: the next generation platform for risk assessment of radiobiology
title_short Organ-on-a-chip: the next generation platform for risk assessment of radiobiology
title_sort organ-on-a-chip: the next generation platform for risk assessment of radiobiology
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057494/
https://www.ncbi.nlm.nih.gov/pubmed/35515392
http://dx.doi.org/10.1039/d0ra05173j
work_keys_str_mv AT quanyi organonachipthenextgenerationplatformforriskassessmentofradiobiology
AT sunmiao organonachipthenextgenerationplatformforriskassessmentofradiobiology
AT tanzhaoyi organonachipthenextgenerationplatformforriskassessmentofradiobiology
AT eijkeljanct organonachipthenextgenerationplatformforriskassessmentofradiobiology
AT vandenbergalbert organonachipthenextgenerationplatformforriskassessmentofradiobiology
AT vandermeerandries organonachipthenextgenerationplatformforriskassessmentofradiobiology
AT xieyanbo organonachipthenextgenerationplatformforriskassessmentofradiobiology